TERT and head and neck squamous cell carcinoma: Although numerous genetic alterations involving a variety of different pathways contribute to the development and progression of HNSCC, 85% of cancers acquire the capability to replicate indefinitely through the re-activation of telomerase, a ribonucleoprotein complex containing an internal RNA component and a catalytic protein, TERT, with telomere specific reverse transcriptase activity6.